(Q48086898)

English

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.

scientific article published on 31 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Shahin Akhondzadeh

8

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

author name string

Amirhossein Gougol

1

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Nahid Zareh-Mohammadi

2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Samira Raheb

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Mehdi Farokhnia

4

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Samrand Salimi

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Negar Iranpour

6

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Habibeh Yekehtaz

7

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

language of work or name

0 references

publication date

31 March 2015

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Journal of Psychopharmacology

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

29

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

575-581

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Long-term use of statins reduces the risk of hospitalization for dementia

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Targeting of NMDA receptors in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Statins and biomarkers of inflammation

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neurons

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Cholesterol and suicide attempts: a prospective study of depressed inpatients

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Decreased plasma BDNF level in depressive patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Acute atorvastatin treatment exerts antidepressant-like effect in mice via the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

New insights into BDNF function in depression and anxiety

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Effects of lovastatin on cognitive function and psychological well-being

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Relationship between major depression and high serum cholesterol in Japanese men.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Statins and their potential targets in multiple sclerosis therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Validity of vascular depression as a specific diagnostic: a review

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Statins of different brain penetrability differentially affect CSF PLTP activity.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

The effects of dietary cholesterol-lowering on psychological symptoms: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Inflammation and depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881115578160

21 January 2018

Identifiers

10.1177/0269881115578160

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25827645

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48086898&oldid=1514271321"